145 KRAS mutation may be one of the chemo-resistant phenotype of ovarian clear cell carcinoma
Yosuke Konno(Hokkaido University of Science), Hidemichi Watari(Hokkaido University of Science), Kanako C-Hatanaka(Hokkaido University Hospital), Takashi Kato(Showa University), Yoshihiro Matsuno(Hokkaido University Hospital), Kei Ihira(Hokkaido University), Yutaka Hatanaka(Hokkaido University), Hiroshi Asano(Hokkaido University), Daisuke Endo(Kishokai Medical Corporation), Takashi Mitamura(Sapporo University), M Sakurai(Hokkaido University), Hiroyuki Yamazaki(Hokkaido University)
Cited by 0
Related Papers
High-capacity electrode materials for rechargeable lithium batteries: Li <sub>3</sub> NbO <sub>4</sub> -based system with cation-disordered rocksalt structure
|Proceedings of the National Academy of Sciences|2015|486
Natural History of Pulmonary Subsolid Nodules: A Prospective Multicenter Study
|Journal of Thoracic Oncology|2016|273
Recurrent rectal cancer and scar: differentiation with PET and MR imaging.
|Radiology|1992|178
Chemotherapy-Induced IL34 Enhances Immunosuppression by Tumor-Associated Macrophages and Mediates Survival of Chemoresistant Lung Cancer Cells
|Cancer Research|2016|178
Long noncoding RNA NEAT1 drives aggressive endometrial cancer progression via miR-361-regulated networks involving STAT3 and tumor microenvironment-related genes
|Journal of Experimental & Clinical Cancer Research|2019|164